Excellence and Expertise
• Research and Innovation
James Flynn co-authors paper on Lousiana's public health efforts against Hepatitus C
Published
Excellence and Expertise
• Research and Innovation
James Flynn co-authors paper on Lousiana's public health efforts against Hepatitus C
Published
Hepatitis C is a major public health concern due to its high rates of infection and mortality. Recent breakthroughs in pharmaceuticals not only have the potential to cure hepatitis C but could also cause large positive health externalities through reduced transmission. The high cost of these drugs under traditional reimbursement schemes create large obstacles to care, but a recent first-of-its-kind two-part tariff system in Louisiana aims to circumvent these obstacles using a modified subscription model with an exclusive pharmaceutical provider. James Flynn and his co-authors found that the program more than pays for itself.
